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We have previously reported on patients with idiopathic membranous glomer- 
ulonephritis considered to  be  mediated by renal  tubular epithelial  antigen. 
Immunoglobulins and fllc, as well as the antigen that had antigenic determi- 
nants in common with the brush border of proximal tubular epithelia, were 
found in  immune deposits along glomerular capillary walls by a  fluorescent 
antibody technique (1, 2). The ~'nephritogenic" tubular antigen (Tub-Ag)  1 was 
purified after it had been solubilized from kidney tissue by digestion with a 
potent proteolytic enzyme, Pronase, and utilizing radiolabeled Tub-Ag, a sensi- 
tive  radioimmunoassay was  developed that  enabled  us  to  identify  Tub-Ag 
activity in the serum, as well as in various organs of humans (3). 
These  findings prompted us  to  purify Tub-Ag of the  rat  with  the  same 
procedure employed to  isolate the Tub-Ag of humans,  in order to develop a 
laboratory model of membranous glomerulonephritis mediated by Tub-Ag-anti- 
body complexes. The rats that received a  single injection of partially purified 
Tub-Ag preparation with adjuvant developed a typical membranous glomerulo- 
nephritis with deposition of homologous immunoglobulin and Tub-Ag along the 
glomerular capillary walls (4). 
In this paper,  we report the distribution of rat  Tub-Ag in the serum and 
various organs, and also, changes in the level of Tub-Ag and the appearance of 
antibodies  against  Tub-Ag in  the  serum of the  rats  with Tub-Ag-mediated 
membranous glomerulonephritis. 
Materials and Methods 
Solubilization and Isolation of Tub-Ag from the Kidney.  Renal tubular epithelial segments 
were prepared from 100g of  cortices by a modified method (4) originally described by Edgington et 
al.  (5). They were suspended in 60 ml of Tris-HC1 buffer (0.02 M, pH 7.8) containing 0.13 M of 
NaC1, and digested by Pronase (0.5 mg/ml; Streptomyces griseus protease; Kaken Chemical Co., 
Tokyo) at 37°C for 12 h. The supernatant was concentrated to 3 ml by negative pressure ultrafiltra- 
tion. 1 ml of concentrated sample containing Tub-Ag was applied to a Bio-Gel Aol.5 M column (bed 
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volume 110 ml; Bio-Rad Laboratories, Richmond, Calif.) and the elution was performed under a 
constant flow of 5 ml/h with the Tris-HC1 buffer in the cold. Tub-Ag was recovered in a  peak of 
optical density at 280 nm (OD2so), which appeared ahead of the position of ~/-globulin (4).  The 
fractions containing Tub-Ag were pooled and concentrated. 
Tub-Ag was further purified by disc electrophoresis in acrylamide gel in a Pyrex glass tube (5 x 
70 ram), according to the method of Davis (6).  The partially purified Tub-Ag in buffer containing 
40%  (wt/vol) of sucrose was applied on spacer gel  (2.5% acrylamide),  layered on separating gel 
(7.5% acrylamide). A current of 4 mA/tube was applied at room temperature for 1 h. Bromphenol 
blue (50 ~1, 0.01%) was added to the upper well as an indicator of migration. 10 tubes were run at a 
time, and one of them was fixed and stained in a solution of acetic acid (7%) containing 1% amido 
black 10B.  By referring to the staining pattern of the gel, unstained gel columns were cut. The 
corresponding sections were pooled and extracted by an aliquot of physiological saline by homoge- 
nizing with a  glass homogenizer and then centrifuging at 100,000 g  for 30 rain. The supernatant 
was concentrated by negative pressure ultrafiltration. 
Solubilization  of Tub-Ag from  Tissues.  Tissues  of kidney,  liver,  lung,  spleen,  intestine, 
stomach, and heart were obtained from normal rats of Wistar strain. 20 g each of tissue were cut 
into small pieces with scissors, washed free of blood with sterile physiological saline, suspended in 
60 ml of Tris-HC1 buffer (Tris 0.02 M, NaC1 0.13 M, pH 7.8), and homogenized in a blender. 30 mg 
Pronase was added to the tissue homogenate and incubated.at 37°C  for 12 h  with shaking. The 
Pronase digest was then centrifuged at 100,000 g  for 60 min. The supernatant was collected and 
concentrated to 3 ml by negative pressure ultraflltration. 
Gel Filtration  and Column Electrophoresis.  1 ml of the concentrated sample containing Tub- 
Ag was applied to a column of Bio-Gel A-1.5 M  (bed volume 110) preequilibrated with Tris buffer, 
and 1-ml fractions were collected by eluting at a flow rate of 5 ml/h. Electrophoresis was carried 
out in a column of Bio-Gel P2 (bed volume 74 ml) in Tris-HC1 buffer (F/2 0.05, pH 8.6, at 4°C). After 
0.6 ml of the sample was applied, the column was eluted with 4 ml of the same buffer. A current of 
3 mA/cm  2 was applied in the cold, and the column was eluted with the buffer at a flow rate of 2 ml/ 
h. 
Analytical  Ultracentrifugation.  Sedimentation coefficients were determined in a Spinco Model 
E analytical ultracentrifuge (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.) spinning 
at 60,067 rpm and 20°C.  Tris-HC1 buffer, 0.02 M, pH 7.8, containing 0.13 M  NaC1 was used as a 
solvent.  Observed sedimentation velocities were  corrected for the  viscosity and density of the 
buffer (S2o.w), but were not extrapolated to zero concentration. 
Radioimmunassay of Tub-Ag and Anti-Tub-Ag.  The Tub-Ag preparation, purified by acryl- 
amide gel electrophoresis, was labeled with 12~I at asp act of 10 izCi/tzg (estimating the E]~m. 230 n~ 
value at 10.0) by the chloramine-T method (7). Test antigen in 50 ~1 of buffer (Tris 0.02 M, NaC1 
0.13 M, bovine serum albumin 200/zg/ml, NaNa 0.1%, pH 8.0) was incubated at room temperature 
for i h with 5 ~1 of the same buffer containing 0.01 ~1 of rabbit antiserum against purified Tub-Ag 
plus 5 ~1 of normal rabbit serum. Then, 5 ng of 125I-labeled  Tub-Ag in 10 ~l of the buffer was added 
and incubated further at 4°C for 18 h. 50 ~1 of goat anti-rabbit ~/-globulin antiserum were added to 
each tube, the resulting precipitate was washed twice with 2.5 ml of Tris-HC1 buffer (Tris 0.02 M, 
NaC1 0.13 M, pH 8.0), and the radioactivity was counted in a ~-counter. The control was set up 
without antigen, and percent inhibition [1  -  (cpm of the sample/cpm of the control)] ×  100,  was 
calculated. Usually, three or more points of twofold antigen dilution were assayed, so as to contain 
50%  inhibition between  two  points.  The  amount  to  induce  50%  inhibition was  defined  as  1 
radioimmunoassay  (RIA)  U  of Tub-Ag.  Tub-Ag activity in column fractions was  compared by 
determining the percent inhibition of an aliquot of samples, and the position of peak activity on 
column chromatographies was determined. Anti-Tub-Ag in the rat serum was determined by the 
following method.  5  ~l of rat serum was incubated with 5 ng of l~SI-labeled Tub-Ag in 10 ~l of 
buffer, and incubated at 4°C for 18 h. Then, 50 ~l of rabbit anti-rat ~-globulin antiserum was added 
and the resulting precipitate was washed twice with Tris-HC1 buffer, and the percent binding 
([cpm in precipitate/total cpm added]  ×  100) was calculated. 
Antisera.  Male albino rabbits weighing 2.5-3.0 kg were immunized. Each received 1 ODzs0 U 
of the sample emulsified in Freund's incomplete adjuvant in footpads and intracutaneously;  1 
OD280 U was defined as the amount of the material contained in 1 ml of the solution that exhibited 
an optical density at 280 nm of 1.0.4 wk later, a booster injection was given with 0.2 OD28o U of the 
antigen. 10 days after the booster injection, rabbits were bled and sera were harvested and stored 
at  -20°C until used. NARUSE,  FUKASAWA,  HIROKAWA,  OIKE,  AND  MIYAKAWA  1349 
Bioassay for Nephritogenicity.  Male rats of Wistar strain weighing 150 g  were used for the 
assay of nephritogenic activity of isolated antigens. Fractions containing antigen were emulsified 
in Freund's complete adjuvant. Each rat received 0.2 ml of emulsion containing 0.10D2so U of the 
sample in rear footpads. Urinary protein was determined by the method of Kingsbury et al.  (8), 
with human  albumin as  a  standard.  Proteinuria  of 200  mg/100  ml or more was  considered as 
pathologic; control rats immunized with saline emulsified in adjuvant passes less than 100 mg/100 
ml of protein into their urine. Blood samples were taken by venipuncture, and sera were collected. 
Kidneys were removed and  examined morphologically and  by fluorescent  antibody  technique. 
Renal tissues were fixed in 10% formalin and embedded in paraffin, cut at 2 pm thick, and stained 
with hematoxylin and eosin, periodic acid-Schiff, and periodic acid methenamine silver. 
For immunofluorescent studies,  the T-globulin fraction of the antiserum was isolated by 33% 
ammonium sulfate precipitation method, and conjugated with fluorescein isothiocyanate (FITC) 
by the method of Wood et al.  (9).  Excess FITC was removed by passing the conjugate through a 
column of Sephadex G-25 (Pharmacia  Fine Chemicals,  Piscataway,  N. J.) preequilibrated with 
phosphate buffer (0.005 M, pH 7.0) containing 0.1 M NaCl. The conjugate was further purified by a 
column of DEAE-cellulose, equilibrated with the phosphate buffer.  Antiserum to rat T-globulin 
was purchased from a  commercial source (Behringwerke AG, Marburg-Lahn,  W. Germany) and 
conjugated with FITC as described above. Kidney tissues were snapfrozen in n-hexane cooled in an 
acetone-dry ice bath and cut at 4 ~m by a cryostat. Kidney sections were fixed in acetone for 3 rain, 
dried  in  the  air,  stained  with  FITC-conjugated  reagents,  and  observed  under  a  fluorescence 
microscope.  To  expose  binding  sites  of antigen  deposited  in  the  glomerular  capillary  walls, 
immunoglobulins were partially eluted by the treatment with acid (0.1 M glycine-HC1 buffer, pH 
2.4,  at 0°C for 10 min) or with enzymatic digestion (trypsin 0.05 mg/ml in 0.02 M Tris-HC1 buffer 
containing 0.13 M NaC1, pH 7.8, at room temperature for 2 rain). After these procedure, sections 
were washed three times in phosphate-buffered saline and stained with fluoresceinated reagents. 
Results 
Isolation of Tub-Ag on Acrylamide Gel Electrophoresis.  Tub-Ag was solubi- 
lized by Pronase from renal tubular epithelial segments,  and partially sepa- 
rated by gel filtration chromatography (4). It was further purified by acrylam- 
ide gel electrophoresis.  The  partially  purified Tub-Ag disclosed five protein 
bands (Fig. 1). These bands, designated as B-1 to B-5 in the increasing order of 
electrophoretic mobility,  were tested for their nephritogenic activity in rats. 
Only the rats immunized with B-3 developed proteinuria after 5-6 wk of the 
injection  (Table  I).  Pathological  findings  in the  kidneys  of these  rats were 
those of a typical membranous glomerulonephritis,  i.e., diffuse thickening of 
the glomerular basement  membrane  without cellular  proliferation  (Fig.  2a 
and b).  Immunofluorescent  study revealed  the deposition  of ~/-globulin  and 
Tub-Ag in diffuse granular fashion along glomerular capillary walls  (Fig.  3 a 
and b ). Six rats were also immunized with 0.01 OD~so U of B-3, one-tenth of the 
amount of antigen used in Table I. Five of them developed proteinuria with all 
the immunopathological hallmarks of Tub-Ag-mediated membranous glomer- 
ulonephritis after a longer incubation period of 60-70 days. 
When the purified Tub-Ag preparation (B-3)  was tested on acrylamide gel 
electrophoresis  for homogeneity,  a  single  sharp  protein band  was  obtained 
(Fig.  1). The protein band of Tub-Ag stained heavily with periodic acid-Schiff 
reagent, but not with Sudan III, indicating its glycoprotein nature. Analytical 
ultracentrifugation was performed on the purified Tub-Ag, and a single sym- 
metrical peak with a S2o.w value of 8.4 was obtained  (Fig.  4).  When purified 
Tub-Ag preparation and rabbit anti-Tub-Ag were tested by a double immuno- 
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Fro.  1.  Disc electrophoresis in acrylamide gel. (1) Tub-Ag preparation partially purified 
by Bio-Gel A-1.5 M column. (3) Tub-Ag purified by disc electrophoresis. 
Tub-Ag Activity  in the Serum and  Tissue Extracts.  Utilizing ~2~I-labeled 
Tub-Ag, a sensitive radioimmunoassay  was developed for the determination of 
Tub-Ag and homologous antibody. Fig. 5 shows a titration curve of Tub-Ag by 
the radioimmunoassay. 
When the serum and Pronase extracts of tissues were tested by the radioim- 
munoassay, they were invariably found to contain Tub-Ag activity. The re- 
sults are given in Table II. Tub-Ag activity extracted per gram of wet tissue by 
Pronase treatment was by far the highest for the kidney, followed  by liver, 
lung, and spleen in the decreasing order. The activity of intestine, stomach, 
and heart were much lower, but they still exhibited up to several times as 
much activity as the untreated serum. The total extractable Tub-Ag activity, 
i.e., the specific activity multiplied by total weight of each organ, was equally 
high  in  kidneys and  liver,  followed by  lungs.  Fig.  6  shows  gel  filtration 
patterns  of the  serum  and  Pronase  extracts  of kidney and  lung.  Tub-Ag 
activity in the serum appeared as a single peak, in ahead of the position of T- 
globulin. Tub-Ag activity in kidney and lung extracts appeared at the same 
position as in the serum. The positions of Tub-Ag activity in Pronase extracts 
of all the organs listed in Table II were the same. 
Fig. 7 illustrates the electrophoretic pattern of rat serum. Tub-Ag activity in 
the serum appeared in three different peaks distributed in regions of a- and fl- NARUSE~  FUKASAWA~  HIROKAWA~  OIKE~  AND  MIYAKAWA  1351 
Fro.  2.  A  glomerulus  from  the  nephritic  rat  killed  80  days  aider  immunization.  (a) 
Marked thickening of the glomerular basement membrane is seen without any noticeable 
cellular proliferation (periodic acid-Sehiff stain  ×  200).  (b) Typical tooth-comb appearance 
is observed (periodic acid-methenamine silver ×  900). 1352  NEPHROGENIC  TUBULAR  ANTIGEN 
FIa.  3.  Fluorescent micrograph ofglomeruli from the same rat as in Fig. 2 (×  400).  (a) 
Kidney section stained  with fluorescinated anti-rat T-globulin reagent.  Diffuse granular 
deposits  of host  T-globulin  are  found  along the  glomerular  capillary  walls.  (b)  Kidney 
section stained with FITC-labeled antibody against Tub-Ag. Note the specific fluor in the 
same pattern  as that of host T-globulin. The luminal layer of tubular epithelium is also 
stained in the right upper corner of the field. NARUSE,  FUKASAWA,  HIROKAWA,  OIKE,  AND  MIYAKAWA 
TABLE  I 
Distribution  of Nephritogenic Activity in Fractions of Disc 
Electrophoresis 
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Distribution of  0D28o  Nephritogenic  activity: 
Fractions  values recovered  nephritic  rats/immu- 
nized rats* 
% 
B-1  4.6  0/6 
B-2  7.1  0/6 
B-3  48.5  0/6 
B-4  30.5  0/6 
B-5  9.2  0/6 
* Each rat received 0.1 OD28o U of antigen. 
Fro.  4.  Ultracentrifugation profile of isolated Tub-Ag (B-3). Photograph was taken at 32 
min with a  bar angle  of 62  °.  Direction  of the sedimentation  is to the right.  A single 
symmetrical peak is seen. 
globulins.  When  the  purified preparation  isolated  from renal  tubular  epithe- 
lia and tissue extracts of  the other organs were tested, a single peak of activity 
appeared at the position of  the one of  the three peaks of serum with the slowest 
electrophoretic mobility. 
Immunoserologic Studies of Rats with Tub-Ag-Mediated Membranous Glo- 
merulonephritis.  A  group  of 40  rats  were  immunized  with  0.1  OD28o U  of 
purified Tub-Ag emulsified with adjuvant.  Four of them were sacrificed at a 
time at intervals, their serum samples were tested for Tub-Ag and anti-Tub- 
Ag activities, and kidney specimens were studied immunohistologically. Their 
urine samples were tested for protein concentration. The results are shown in 
Table III. Between 15 and 30 days after the immunization, Tub-Ag disappeared 
from the circulation of all the rats tested, and they invariably developed anti- 1354  NEPHROGENIC  TUBULAR  ANTIGEN 
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Tub-Ag  in  the  serum.  At  this  period,  however,  proteinuria  had  still  not 
appeared. In all the rats tested, proteinuria appeared as late as 35-40 days 
after the  injection. Tub-Ag and anti-Tub-Ag in the serum varied after the 
appearance  of proteinuria;  in  some  Tub-Ag reappeared  in  the  circulation 
without detectable free anti-Tub-Ag, while in others anti-Tub-Ag persisted in 
the serum. Pathological findings in the kidney of rats after the development of 
proteinuria were those of typical membranous glomerulonephritis, with depo- 
sition  of 7-globulin  and  homologous Tub-Ag  in  a  granular  fashion  along 
glomerular capillary walls (Fig. 3 a  and b). 
Discussion 
Membranous glomerulonephritis has generally been accepted as a  typical 
glomerular lesion mediated by immune complexes, since immunoglobulins 
and Blc are invariably found in diffuse granular fashion along the glomerular 
capillary walls  (10,  11). Some of the antigens that form immune complexes 
have been identified. Except for DNA in systemic lupus erythematosus (12, 
13), however, most of the responsible agents thus far identified are heterolo- 
gous antigens such as malarial  (14), syphilitic (15, 16), streptococcal (17), and 
viral  (18) antigens. The glomerular injury mediated by these exogenous anti- 
gens is not self-perpetuating; it disappears when the pathogenic organism has 
been eradicated by the specific therapy. A continuous supply of the antigen 
seems to be required for the maintenance of pathologic process in this type of 
glomerulonephritis, as has been clearly shown by Dixon et al.  in the experi- 
mental immune-complex nephritis mediated by bovine serum albumin-anti- 
bovine serum albumin complexes (19). NARUSE,  FUKASAWA,  HIROKAWA,  OIKE,  AND  MIYAKAWA 
TABLE II 
Tubular Antigenic Activity in Rat Tissue Extracts 
1355 
Organ  Tub-Ag  activity  Relative  activity 
RIA U*/g 
Kidney  182,000  788 
Liver  22,200  96 
Lung  11,900  52 
Spleen  3,260  14 
Intestine  2,500  11 
Stomach  758  3 
Heart  520  2 
Serums  231  1 
* Radioimmunoassay units. 
$ Activity of untreated serum. 
We have found deposition of renal tubular epithelial antigen together with 
immunoglobulins and fllc along the glomerular capillary walls of some pa- 
tients with "idiopathic" membranous glomerulonephritis (1, 2). The protein- 
uria of the nephritic patients with the glomerular deposition of tubular anti- 
gen-antibody complexes persisted without episodes of remission (2).  We have 
solubilized the nephritogenic tubular  antigen  (Tub-Ag)  from renal  tubular 
epithelia of humans with Pronase and isolated Tub-Ag that was physicochemi- 
cally homogenous and antigenically pure (3). By radioimmunoassay, the Tub- 
Ag of humans was found to be widely distributed in the serum and various 
organs (3). 
The experimental membranous glomerulonephritis in rats reported here is 
considered to be the laboratory counterpart of the human glomerulonephritis 
mediated by Tub-Ag-antibody complexes, which has been reported by us and 
confirmed by Strauss and co-workers (20), because (a) Tub-Ags of  both humans 
and rats have been solubilized and purified by the same method and found to 
be glycoproteins associated with essentially the same physicochemical charac- 
ters in terms of molecular size, electrophoretic mobility, and s20,w value; (b) in 
the kidney, Tub-Ag of both humans and rats localized exclusively in the brush 
border of proximal tubular epithelia; (c) Tub-Ag activities were identified in 
the sera of  both humans and rats, and they were borne by a protein of  the same 
size as the Tub-Ag purified from homologous renal tubular epithelia; and (d) 
the Tub-Ag activity was liberated by Pronase treatment not only from the 
kidney, but also from all the other organs tested including liver, lung, intes- 
tine  and  so  forth,  and the  concentration of Tub-Ag in  each human organ 
approximately paralleled that in the rat organ. 
Tubular antigens have long been used to produce experimental glomerulo- 
nephritis. Heymann et al. first produced membranous glomerulonephritis by 
injecting rats repeatedly with homologous kidney homogenate emulsified in 
adjuvant (21). Edgington and collaborators refined this model by employing a 
single injection of purified tubular antigen designated as RTE a5 for immuni- 
zation (22). RTE a5 was liberated from renal tubular epithelia by treatment 
with detergent and borne by a macromolecule oflipoprotein nature with a S2o.w 
value  of 28.6  and  an  electrophoretic  mobility  in  a-globulin  region.  It  was 1356 
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apparently different from Tub-Ag, which was solubilized by Pronase digestion 
and borne by a  glycoprotein with a s2o.w value of 8.4 and an electrophoretic 
mobility in  B-globulin region.  In the kidney, however, both of them were 
localized in the brush border of proximal tubular epithelial cells, and they 
were equally potent in nephritogenicity. There is a possibility, therefore, that 
both of RTE ~5 and Tub-Ag bear the same antigehic determinants present on 
the cellular membrane of proximal tubular epithelia. The essential difference TABLE  III 
Followup of Nephritogenic Tubular Antigen and Homologous  Antibody in the Sera of 
Immunized Rats 
Rats  Days after  in-  Antibody to 
jection  Tub-Ag  Tub-Ag*  Proteinuria 
RIA U/ml  %  mg/lO0 ml 
Normal  0  231  ±  225  <0.7  <30 
Immunized 
1  10  104  6.2  50 
2  10  125  4.6  26 
3  10  250  3.5  30 
4  15  29  17.2  26 
5  15  42  46.1  38 
6  20  26  28.9  65 
7  20  43  21.4  34 
8  25  36  29.6  30 
9  25  54  39.5  46 
10  25  80  68.1  28 
11  25  25  27.2  34 
12  30  44  68.2  40 
13  30  32  58.2  36 
14  30  83  29.1  20 
15  30  29  77.5  50 
16  35  114  6.9  175 
17  35  217  6.1  540 
18  35  95  16.2  1,700 
19  35  175  6.2  170 
20  40  100  13.1  1,400 
21  40  122  7.2  2,300 
22  40  50  23.6  2,100 
23  40  95  41.6  1,800 
24  45  33  61.0  1,900 
25  45  37  68.7  2,300 
26  45  222  4.7  1,400 
27  45  172  5.6  970 
28  50  95  74.8  650 
29  50  95  61.0  2,000 
30  50  222  4.5  1,800 
31  60  125  26.4  1,200 
32  60  169  38.9  2,100 
33  60  217  7.0  980 
34  80  217  10.7  2,300 
35  80  120  6.7  800 
36  80  238  1.9  1,100 
37  90  87  24.2  2,000 
38  90  161  13.9  1,800 
39  90  215  1.9  2,000 
* Percent of 5 ng of 12SI-labeled Tub-Ag bound with 5 ~l of the serum. 
5 Mean _+  SD of 10 normal rats. 
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between the method of Edgington et al. and ours is the technique employed to 
solubilize the antigen. They used a  detergent, while we used a  proteolytic 
enzyme. Different sites of membrane may have been cleaved by these two 
kinds of treatment to produce molecular fragments of dissimilar sizes,  but 
containing the same antigenic configurations. Similar observations have been 
reported  in  the  solubilization  of HL-A  antigens  from  cellular  membranes. 
When cells were treated with detergents, the antigenic activity of HL-A was 
obtained in macromolecules  with a molecular size of a few million daltons (23). 
In contrast, much smaller molecules with a size of 48,000 daltons, bearing the 
same antigenicity, were liberated by digesting cellular membranes with pa- 
pain (24). Possibly Tub-Ag can be incorporated in RTE ~5 in the same way. It 
would be of interest to digest RTE ~5 with Pronase to see if the nephritogenic 
activity can be recovered in a smaller molecule. It may be justified to assume, 
however, that Tub-Ag is somewhat more physiologic than RTE ~5 because the 
activity of Tub-Ag was found to occur naturally in the serum, associated with 
physicochemical properties  identical to  those  of Tub-Ag purified from the 
kidney, and to  those  from all  the  other organs  tested.  Tub-Ag may exist 
ubiquitously as a component of cellular membrane in a number of organs, and 
be released into the circulation as a physiological metabolite. Since it is clear 
that a glycoprotein bearing the antigenicity of Tub-Ag is not specific to renal 
tubular epithelia, the terminology, by definition, is no longer  justified. We are 
inclined to retain the term Tub-Ag, however, until a more appropriate nomen- 
clature is available to characterize it,  for example, as a  distinct molecular 
component of cellular membranes. 
Although Tub-Ag  in  the  rat  serum  was  homogeneous in  size  by  a  gel 
filtration criterion, it revealed three different electrophoretic mobilities dis- 
tributed widely in a- and f~-globulin regions. Such a heterogeneity in electro- 
phoretic mobility was  also  observed for Tub-Ag in  human serum  (3). The 
electrophoretic mobility of Tub-Ag purified from the kidney was homogeneous 
and identical to one of the peaks of Tub-Ag in the serum that had the slowest 
mobility. The Tub-Ag activities in the serum with faster mobilities would 
probably be associated with additional molecules with negative charges, such 
as sialic acid. 
Glassock et al. have found that radiolabeled rabbit anti-RTE a5 was cleared 
from circulation much faster than the pair-labeled normal rabbit ~/-globulin, 
and suggested the presence of tubular antigen activities in the serum of rats 
(25). With radioimmunoassay, tubular antigen was directly demonstrated in 
the serum of rats, confirming their observations. The reason why the previous 
workers had difficulties in detecting tubular antigens in the serum, although 
their presence had been strongly suspected, was apparently their low concen- 
tration in the circulation. Circulating Tub-Ag would have been responsible for 
the experimental glomerulonephritis in rats induced by the passive transfer of 
heterologous as well as homologous antibodies against tubular antigens. Feen- 
stra  and his  associates have  injected rats with rabbit  antibody to  tubular 
epithelial  antigen  and  demonstrated the  deposition  of immune complexes 
containing the antigen and heterologous antibody in the glomerular basement 
membrane as early as 3 h  aider the injection (26). Sugisaki et al. transferred 
the Heymann-type glomerulonephritis by the v-globulin fraction of sera of NARUSE,  FUKASAWA~ HIROKAWA~ OIKE,  AND  MIYAKAWA  1359 
nephritic rats (27). Their findings were at variance with those of Hess et al., 
who failed to induce nephritis by the injection of sera of diseased animals (28). 
Circulating free antibodies against tubular antigen in the rats with Heymann- 
type glomerulonephritis have been a matter of  controversy. Hunter and collab- 
orators found the antibody by immunodiffusion  in sera of  only one-fourth of the 
nephritic rats (29). Glassock and his co-workers used the inhibition of staining 
of brush  border  by  fluoresceinated  antibody  and  demonstrated antibodies 
within the period of 3-8 wk after the immunization (25). Utilizing radioimmu- 
noassay, we have shown that free antibody to Tub-Ag appeared in the serum of 
all the rats tested about 15-30 days after inoculation, earlier than the develop- 
ment of  proteinuria. Thereafter, anti-Tub-Ag antibody persisted in some of the 
rats,  while it disappeared from circulation in  others.  The reason why free 
antibody  may  or  may  not  be  detected  in  the  nephritic  rats  without  any 
noticeable  difference  in  the  degree  of proteinuria  or  immunopathological 
changes in the kidney remains unexplained. 
It is of interest that Tub-Ag was demonstrated not only in the kidney, but 
also universally in all the other organs tested. The antigenicity in common 
with the brush  border of renal  tubular epithelia has  already been demon- 
strated in the intestine of rats by fluorescent antibody technique (5). A number 
of  experiments have been undertaken to detect tubular antigen in organs other 
than kidney by inducing Heymann-type glomerulonephritis by the injection 
with extracts of various organ tissues,  including liver, lung, intestine, and 
stomach, without any success (22, 27), except in the report of Heymann et al., 
who noted that 3 out of 21 rats immunized with liver homogenate emulsified in 
adjuvant developed glomerulonephritis (21). This would have been attributa- 
ble to lower concentrations of the antigen contained in these organs. Although 
the kidney contained by far the highest Tub-Ag per gram of wet tissue among 
all the organs tested, the total antigenic activity in the organs such as liver 
and lung was comparable to that in kidneys, owing to their respective weight. 
Evidence that kidneys accounted for only a  part of circulating Tub-Ag has 
already been obtained in humans. Tub-Ag activity was detected in the serum 
of patients on maintenance hemodialysis who received bilateral nephrectomy, 
although at a slightly lower level than normal individuals (60.8 _+ 7.8 vs. 69.9 
_+ 10.6 RIA U/ml) (3). Taken altogether, organs other than kidney seem to be 
greater sources of circulating Tub-Ag. 
There remains little doubt that circulating Tub-Ag maintains the pathologic 
process in the kidney both in humans and in rats by supplying the antigen 
continuously to form immune complexes. In experimental membranous glo- 
merulonephritis in rats, antibody responses were initiated by immunizing rats 
with homologous Tub-Ag purified from the kidney. In the human version of 
this  type  of glomerulonephritis, however,  the  way  in  which the  antibody 
response  to  Tub-Ag  is  triggered  remains  to  be  determined.  The  primary 
antibody response to Tub-Ag could have occurred against Tub-Ag in almost 
any organ. Just as the heterologous antibody raised against tissue homogenate 
of any organ  always  bound with  the glomerular basement membrane and 
induced Masugi-type glomerulonephritis in rats  (30),  and the injury in the 
lung  has  been  implicated  for  the  production of nephrotoxic antibodies  in 
Goodpasture's syndrome in  humans  (31,  32),  the  kidney could again  be  a 1360  NEPHROGENIC  TUBULAR  ANTIGEN 
universal sufferer  in Tub-Ag-mediated membranous glomerulonephritis.  We 
are now immunizing rats with Tub-Ag preparations isolated from the other 
organs containing RIA units comparable to those from the kidney which were 
sufficient to induce membranous glomerulonephritis to determine the validity 
of this assumption. 
Summary 
The renal tubular epithelial antigen  (Tub-Ag) of rats  was  solubilized by 
Pronase  and  purified by  gel  filtration  and  acrylamide gel  electrophoresis. 
Purified Tub-Ag was a  glycoprotein with s2o.w value of 8.4.  Utilizing radiola- 
beled  Tub-Ag,  a  sensitive  radioimmunoassay for  Tub-Ag  and  homologous 
antibody  (anti-Tub-Ag)  was  developed.  Tub-Ag  activity  associated  with  a 
protein of the same molecular size was demonstrated in the serum, as well as 
in  Pronase  extracts  of all  the  organs  tested,  including kidney,  liver,  lung, 
spleen,  intestine,  stomach,  and heart.  The physicochemical properties of the 
Tub-Ag of rats and its distribution were essentially the same as the Tub-Ag of 
humans,  which had been found in  immune deposits  in the kidney of some 
patients with idiopathic membranous glomerulonephritis.  Rats were immu- 
nized with the purified Tub-Ag emulsified in Freund's complete adjuvant and 
followed for Tub-Ag and anti-Tub-Ag in the serum, as well as for proteinuria 
and immunohistological changes in the kidney. Serum Tub-Ag dropped sharply 
after 20 days, when anti-Tub-Ag appeared in the circulation. Persistent, mas- 
sive proteinuria appeared still later, more than 30 days after injection, when 
anti-Tub-Ag disappeared and Tub-Ag reappeared in the serum of some of those 
rats. In others, anti-Tub-Ag in the serum persisted throughout the observation 
period of 90 days. The pathology of the kidney of the rats with proteinuria was 
that  of a  typical  membranous glomerulonephritis; thickening of glomerular 
capillary walls with granular deposits of T-globulin and Tub-Ag was observed. 
On the basis  of these results,  Tub-Ag in the serum,  probably released from 
cellular membranes of various organs as a  physiological metabolite, is consid- 
ered to maintain the pathological process in the kidney by providing the antigen 
continuously to form immune complexes. 
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